PHSC plc 04 July 2005 PHSC plc Admission to AIM PHSC plc ("PHSC" or the "Company"), today announces that, with effect from 08.00am today (4 July 2005), its existing ordinary shares of 10p each ("Ordinary Shares") have been admitted to AIM. Ruegg & Co Limited is acting as the nominated adviser and broker. Words and expressions defined in the Admission Document published on 28 June 2005 shall have the same meaning as in this announcement. Key Statistics Number of Ordinary Shares in issue immediately following Admission 9,785,504 Market Capitalisation of the Company at 64.5p per share (being the mid-price as quoted on Ofex at close of business on 27 June 2005) GBP6,311,650 The Company, through its three wholly-owned operating subsidiaries (being PHSCL, RSA and ALS), is a provider of health, safety and environmental services to corporate and public sector clients. The revenues of PHSCL, now a wholly-owned subsidiary of the Company, were £37,000 for the year ended 31 March 1992, which was the first full year of trading. Revenues have demonstrated a consistent upward trend since then such that the revenues of the Group, which now comprises a holding company, three operating subsidiaries and four dormant subsidiaries, were £2,217,450 for the year ended 31 March 2005. The pre-tax profit for the year was £476,112. Since the year end the Company acquired ALS which for the ten month period to 28 February 2005 had revenues of £1,495,245 and reported pre-tax profits of £332,790. During 2004 the Company embarked upon a proactive acquisition strategy seeking contracts or businesses within the health and safety consultancy sector. The Company, which has its headquarters in Aylesford in Kent, was incorporated on 8 December 2000 and is the holding company of the Group. The Company's shares were admitted to trading on Ofex on 3 June 2003, since when the Company has acquired three businesses complementary to that of PHSCL. - Ends - For further information, please contact: PHSC plc Ruegg & Co Limited Stephen King Gavin Burnell T: 01622 717700 T: 020 7584 3663 This information is provided by RNS The company news service from the London Stock Exchange EN